Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueReceivables - NetRevenue (Gross)
Ratios

BioRestorative Therapies (BRTX) Long-Term Debt Issuances (2016 - 2020)

BioRestorative Therapies (BRTX) has disclosed Long-Term Debt Issuances for 10 consecutive years, with $3.8 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Long-Term Debt Issuances rose 50.59% year-over-year to $3.8 million, compared with a TTM value of $4.3 million through Dec 2020, down 60.6%, and an annual FY2020 reading of $4.3 million, down 60.6% over the prior year.
  • Long-Term Debt Issuances was $3.8 million for Q4 2020 at BioRestorative Therapies, up from $441762.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $5.0 million in Q4 2018 and bottomed at -$1.4 million in Q3 2018.
  • Average Long-Term Debt Issuances over 5 years is $1.2 million, with a median of $500000.0 recorded in 2016.
  • The sharpest move saw Long-Term Debt Issuances tumbled 300.36% in 2017, then skyrocketed 1300.97% in 2018.
  • Year by year, Long-Term Debt Issuances stood at -$1.1 million in 2016, then increased by 24.61% to -$831485.0 in 2017, then skyrocketed by 703.62% to $5.0 million in 2018, then crashed by 49.08% to $2.6 million in 2019, then skyrocketed by 50.59% to $3.8 million in 2020.
  • Business Quant data shows Long-Term Debt Issuances for BRTX at $3.8 million in Q4 2020, $441762.0 in Q1 2020, and $2.6 million in Q4 2019.